| Summary of Basic and Diluted Earnings Per Share |
The following tables present our basic and diluted earnings per share: Basic Earnings Per Common Share | | | | | | | | | | | | | | | | (Canadian $ in millions, except as noted) | For the three months ended | For the nine months ended | | July 31, 2026 | July 31, 2025 | July 31, 2026 | July 31, 2025 | | Net income attributable to bank shareholders | $ | 1,748 | | $ | 2,327 | | $ | 6,864 | | $ | 6,421 | | | Dividends on preferred shares and distributions on other equity instruments | (81) | | (66) | | (301) | | (273) | | | Net income available to common shareholders | $ | 1,667 | | $ | 2,261 | | $ | 6,563 | | $ | 6,148 | | | Weighted-average number of common shares outstanding (in thousands) | 699,361 | | 719,514 | | 703,487 | | 724,820 | | | Basic earnings per common share (Canadian $) | $ | 2.38 | | $ | 3.14 | | $ | 9.33 | | $ | 8.48 | |
Diluted Earnings Per Common Share | | | | | | | | | | | | | | | | (Canadian $ in millions, except as noted) | For the three months ended | For the nine months ended | | July 31, 2026 | July 31, 2025 | July 31, 2026 | July 31, 2025 | | Net income available to common shareholders | $ | 1,667 | | $ | 2,261 | | $ | 6,563 | | $ | 6,148 | | | Weighted-average number of common shares outstanding (in thousands) | 699,361 | | 719,514 | | 703,487 | | 724,820 | | Dilutive impact of stock options (1) | | | | | Stock options potentially exercisable | 5,252 | | 5,597 | | 5,423 | | 5,912 | | | Common shares potentially repurchased | (2,932) | | (4,318) | | (3,526) | | (4,751) | | | Weighted-average number of diluted common shares outstanding (in thousands) | 701,681 | | 720,793 | | 705,384 | | 725,981 | | | Diluted earnings per common share (Canadian $) | $ | 2.38 | | $ | 3.14 | | $ | 9.30 | | $ | 8.47 | |
(1)The dilutive effect of stock options was calculated using the treasury stock method. In computing diluted earnings per share, we excluded average stock options outstanding of nil and 422,800 with a weighted-average exercise price of $nil and $199.52 for the three and nine months ended July 31, 2026, respectively (716,633 and 635,554 with a weighted-average exercise price of $149.35 and $150.96 for the three and nine months ended July 31, 2025, respectively), as the average share price for the periods did not exceed the exercise price.
|